4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001915598-26-000007
Chief Commercial Officer sold 231 shares at $16.82 ($3,885)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Friedl-Naderer Johanna · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-13 | Sale : show line 1 in the form 10b5-1 | −231 | $16.82 | $3,885 | 152,666 | D |
| Open-market sales · 231 sh · avg $16.82 · $3,885 | ||||||
Loading xslF345X06/ownership.xml…